1538.Tw

The company's capital structure shows a debt-to-equity ratio of 0.48, indicating a relatively conservative leverage position compared to the industry median. However, the negative operating cash flow of -64.41 million TWD and free cash flow of -65.12 million TWD suggest liquidity constraints. The price-to-book ratio of 2.75 implies that the market values the company at a premium to its book value, but the negative return on equity of -37.18% and return on assets of -20.02% indicate poor profitability.

Profitability metrics are significantly below industry norms, with the company reporting a net loss of 51.39 million TWD and an operating loss of 49.20 million TWD. The gross profit margin of 23.06% is also below the industry median, suggesting inefficiencies in cost management or pricing power. The company's EBITDA multiple of -9.07 further highlights the unprofitable nature of its operations.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of individual product lines or markets.

The company's growth trajectory is negative, with a net loss in the current fiscal year and no indication of improvement in the next fiscal year. The capital expenditure of -29.21 million TWD suggests a reduction in investment, which may further hinder future growth. The company's operating cash flow and free cash flow are both negative, indicating a lack of internal resources to fund expansion or debt servicing.

The company faces medium liquidity risk due to its negative net cash position after subtracting total debt. The dilution risk is low, as there is no indication of share issuance or dilution in the near term. The company's financial adjustments, such as the negative operating cash flow and free cash flow, highlight the need for improved cash management and cost control.

Recent filings and transcripts do not provide specific details on the company's strategic initiatives or financial performance. The lack of detailed disclosures limits the ability to assess the company's response to market challenges and its long-term viability.